MedPath

KVK-Tech, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

31

FDA:31

Drug Approvals

Leflunomide

Approval Date
Jun 23, 2025
FDA

Carmustine

Approval Date
Mar 5, 2024
FDA

Methylphenidate Hydrochloride

Approval Date
Mar 4, 2024
FDA

Sodium Polystyrene Sulfonate

Approval Date
Feb 23, 2024
FDA

Desmopressin Acetate

Approval Date
Feb 21, 2024
FDA

Dexmethylphenidate Hydrochloride

Approval Date
Feb 19, 2024
FDA

INDOMETHACIN

Approval Date
Feb 19, 2024
FDA

METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE

Approval Date
Feb 16, 2024
FDA

BETAXOLOL HYDROCHLORIDE

Approval Date
Feb 14, 2024
FDA

Phentermine Hydrochloride

Approval Date
Feb 14, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.